You have full text access to this OnlineOpen article

Imaging in cervical cancer

  1. Michele Follen M.D., Ph.D.1,†,*,
  2. Charles F. Levenback M.D.1,
  3. Revathy B. Iyer M.D.2,
  4. Perry W. Grigsby M.D.3,
  5. Erik A. Boss M.D.4,
  6. Ebrahim S. Delpassand M.D.5,
  7. Bruno D. Fornage M.D.2,
  8. Elliot K. Fishman M.D.6

Article first published online: 22 OCT 2003

DOI: 10.1002/cncr.11679

Issue

Cancer

Cancer

Special Issue: Proceedings of the Second International Conference on Cervical Cancer

Supplement: Second International Conference on Cervical Cancer

Volume 98, Issue Supplement S9, pages 2028–2038, 1 November 2003

Additional Information

How to Cite

Follen, M., Levenback, C. F., Iyer, R. B., Grigsby, P. W., Boss, E. A., Delpassand, E. S., Fornage, B. D. and Fishman, E. K. (2003), Imaging in cervical cancer. Cancer, 98: 2028–2038. doi: 10.1002/cncr.11679

Author Information

  1. 1

    Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  2. 2

    Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  3. 3

    Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri

  4. 4

    Department of Gynecology and Obstetrics, University Medical Center St. Radboud Nijmegen, Nijmegen, The Netherlands

  5. 5

    Department of Nuclear Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  6. 6

    Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland

  1. †

    Fax: (713) 792-4856

*Center for Biomedical Engineering, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 193, Houston, TX 77030

Publication History

  1. Issue published online: 22 OCT 2003
  2. Article first published online: 22 OCT 2003
  3. Manuscript Received: 31 OCT 2003
  4. Manuscript Accepted: 7 FEB 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (164K)

REFERENCES

  • 1
    Grigsby PW, Dehdashti F, Siegel BA. FDG-PET evaluation of carcinoma of the cervix. Clin Positron Imaging. 1999; 2: 105–109.
  • 2
    Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomorgraphy in patients with carcinoma of the cervix. J Clin Oncol. 2001; 19: 3745–3749.
  • 3
    Reinhardt M, Ehritt-Braun D, Vogelgesang D, et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology. 2001; 218: 776–782.
  • 4
    Sugawara A, Eisbruch S, Kosuda S, Recker BE, Kison PV, Wahl RL. Evaluation of FDG-PET in patients with cervical cancer. J Nucl Med. 1999; 40: 1125–1131.
  • 5
    Rose P, Adler L, Rodriguez M, et al. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol. 1999; 17: 41–45.
  • 6
    Miller TR, Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys. 2002; 53: 353–359.
  • 7
    Benedet JL, Odicino F, Maisonneuve P, et al. Carcinoma of the cervix uteri. J Epidemiol Biostat. 2001; 6: 7–43.
  • 8
    SobinLH, WittekindC, editors. TNM classification of malignant tumours, 6th edition. New York: John Wiley & Sons, 2002.
  • 9
    Benedet J, Odicino F, Maisonneuve P, et al. Carcinoma of the cervix uteri. Annual report on the results of treatment in gynecological cancer. J Epidemiol Biostat. 1998; 3: 5–34.
  • 10
    Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumor size and morphology on the outcome of patients with FIGO Stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1994; 29: 9–16.
  • 11
    De Gaetano AM, Vecchioli A, Minordi M, et al. Role of diagnostic imaging in abdominal lymphadenopathy. Rays. 2000; 25: 463–484.
  • 12
    Hacker NF. Cervical cancer. In: BerekJS, HackerNF. Practical gynecologic oncology, 3rd edition. Philadelphia: Lippincott Williams & Wilkins, 2000: 345–405.
  • 13
    Eifel PJ, Berek JS, Thigpen JT. Cancer of the cervix, vagina, and vulva. In: DeVitaVT, HellmanS, RosenbergSA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott Williams & Wilkins, 1997: 1433–1478.
  • 14
    Chung CK, Nahhas WA, Stryker JA, Curry SL, Mortel R. Analysis of factors contributing to treatment failures in Stages IB and IIA carcinoma of the cervix. Am J Obstet Gynecol. 1980; 138: 550–556.
  • 15
    Fuller AF, Elliott N, Kosloff C, Lewis JL. Lymph node metastases from carcinoma of the cervix, Stages IF and IIA: implications for prognosis and treatment. Gynecol Oncol. 1982; 13: 165–174.
  • 16
    Nahhas WA, Sharkey FE, Whitney CW, et al. The prognostic significance of vascular channel involvement and deep stromal penetration in early cervical carcinoma. Am J Clin Oncol. 1983; 6: 259–264.
  • 17
    Boyce JG, Fruchter RG, Nicastri AD, et al. Vascular invasion in Stage I carcinoma of the cervix. Cancer. 1984; 53: 1175–1180.
    Direct Link:
  • 18
    Burke TW, Hoskins WF, Heller PB, Bibro MC, Weiser EB, Park RC. Prognostic factors associated with radical hysterectomy failure. Gynecol Oncol. 1987; 26: 153–159.
  • 19
    Delgado G, Bundy B, Zaino R, et al. Prospective surgical-pathological study of disease-free interval in patients with Stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990; 38: 352–357.
  • 20
    Kamura T, Tsukamoto N, Tsuruchi N, et al. Mulitvariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer. 1992; 69: 181–186.
    Direct Link:
  • 21
    Van Nagell JR, Breenwell N, Powell DF, et al. Microinvasive carcinoma of the cervix. Am J Obstet Gynecol. 1983; 145: 981–989.
  • 22
    Hasumi K, Sakamoto A, Sugano H. Microinvasive carcinoma of the uterine cervix. Cancer. 1980; 45: 928–931.
    Direct Link:
  • 23
    Simon NL, Gore H, Shingleton HM, et al. Study of superficially invasive carcinoma of the cervix. Am J Obstet Gynecol. 1983; 145: 981–991.
  • 24
    Maiman MA, Fruchter RG, Di Maio TM, Boyce JG. Superficially invasive squamous cell carcinoma of the cervix. Obstet Gynecol. 1988; 72: 399–403.
  • 25
    Buckley SL, Tritz DM, van Le L, et al. Lymph node metastases and prognosis in patients with Stage IA2 cervical cancer. Gynecol Oncol. 1996; 63: 4–9.
  • 26
    Creasman WT, Zaino RJ, Major FJ, et al. Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study. Am J Obstet Gynecol. 1998; 178: 62–65.
  • 27
    Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with Stage IB cervical carcinoma. Gynecol Oncol. 1995; 59: 38–44.
  • 28
    Lewis E. The use and abuse of imaging in gynecologic cancer. Cancer. 1987; 60: 1993–2009.
    Direct Link:
  • 29
    Piver MS, Wallace D, Castro JR. The accuracy of lymphangiography in carcinoma of the uterine cervix. AJR Am J Roentgenol. 1971; 111: 278–283.
  • 30
    Kim SH, Han MC. Invasion of the urinary bladder by uterine cervical carcinoma: evaluation with MR imaging. AJR Am J Roentgenol. 1997; 168: 393–397.
  • 31
    Levenback C, Coleman RL, Burke TW, et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 2002; 20: 688–693.
  • 32
    Malur S, Krause N, Kohler C, Schneider A. Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol. 2001; 80: 254–257.
  • 33
    Janus CL, Mendelson DS, Moore S, et al. Staging of cervical carcinoma: accuracy of magnetic resonance imaging and computed tomography. Clin Imaging. 1989; 13: 114–116.
  • 34
    Kim SH, Choi BI, Han JK, et al. Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients. J Comput Assist Tomogr. 1993; 17: 633–640.
  • 35
    Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol. 1995; 86: 43–50.
  • 36
    Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol. 2000; 175: 759–766.
  • 37
    Littenberg B. Technology assessment in medicine. Acad Med. 1992; 67: 424–428.
  • 38
    Wallace S, Jackson L, Schaffer B, et al. Lymphangiograms, their diagnostic and therapeutic potentials. Radiology. 1961; 76: 179–199.
  • 39
    Macis G, Cina A, Pedicelli A, Resaino G, Molinari F. Lymph node imaging: from conventional radiology to diagnostic imaging. Rays. 2000; 25: 399–417.
  • 40
    Hricak H. Role of imaging in the evaluation of pelvic cancer. Important Adv Oncol. 1991: 103–133.
  • 41
    LeGasse LD, Gresman WT, Shingleton HM, Ford JH, Blessing JA. Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol. 1980; 9: 90–98.
  • 42
    Ginaldi S, Wallace S, Jing BS, et al. Carcinoma of the cervix: lymphangiography and computed tomography. AJR Am J Roentgenol. 1982; 136: 1087–1091.
  • 43
    Innocenti P, Pulli F, Savino L, et al. Staging of cervical cancer: reliability of transrectal US. Radiology. 1992; 185: 201–205.
  • 44
    Magee BJ, Logue JP, Swindell R, McHugh D. Tumor size as a prognostic factor in carcinoma of the cervix: assessment by transrectal ultrasound. Br J Radiol. 1991; 64: 812–815.
  • 45
    Gitsch G, Deutinger J, Renthaller A, Breitenecker G, Bernaschek G. Cervical cancer: the diagnostic value of rectosonography for the judgment of parametrial invasion in regard of inflammatory stromal reaction. Br J Obstet Gynaecol. 1993; 100: 696–697.
  • 46
    Cobby M, Browning J, Jones A, Whipp E, Goddard P. Magnetic resonance imaging, computed tomography and endosonography in the local staging of carcinoma of the cervix. Br J Radiol. 1990; 63: 673–679.
  • 47
    Hricak H, Yu KK. Radiology in invasive cervical cancer. AJR Am J Roentgenol. 1996; 167: 1101–1108.
  • 48
    Carter J, Carson LF, Elg S. Transvaginal sonography as an aid in the clinical staging of carcinoma of the cervix. J Clin Ultrasound. 1992; 20: 283–287.
    Direct Link:
  • 49
    Hricak H, Lacey CG, Sandles LG, et al. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology. 1988; 166: 623–631.
  • 50
    Ascher SM, Takahama J, Jha RC. Staging of gynecologic malignancies. Top Magn Reson Imaging. 2001; 12: 105–129.
  • 51
    Yamashita Y, Baba T, Baba Y, et al. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology. 2000; 216: 803–809.
  • 52
    Boss EA, Massuger LE, Pop LA, et al. Post-radiotherapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma. J Magn Reson Imaging. 2001; 13: 600–606.
    Direct Link:
  • 53
    Boss EA, Barentsz JO, Massuger LF, Boonstra H. The role of MR imaging in invasive cervical carcinoma. Eur Radiol. 2000; 10: 256–270.
  • 54
    Hricak H, Powell CB, Yu KK, et al. Invasive cervical carcinoma: role of MR imaging in pretreatment work-up—cost minimization and diagnostic efficacy analysis. Radiology. 1996; 198: 403–409.
  • 55
    Narayan K, Hicks RJ, Jobling T, Bernshaw D, McKenzie AF. A comparison of MRI and PET scanning in surgically staged loco-regionally adanced cervical cancer: potential impact on treatment. Int J Gynecol Cancer. 2001; 11: 263–271.
    Direct Link:
  • 56
    Stehman FB, Bundy BN, DiSaia PJ, et al. Carcinoma of the cervix treated with radiation therapy. I. A multivariate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer. 1991; 67: 2776–2785.
    Direct Link:
  • 57
    Mutic S, Malyapa RS, Grigsby PW, et al. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes—a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys. 2003; 55: 28–35.
  • 58
    Lewis JS, McCarthy DW, McCarthy TJ, et al. The evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J Nucl Med. 1999; 40: 177–183.
  • 59
    Lewis JS, Sharp TL, Laforest R, et al. Tumor uptake of copper-diacetyl-bis(N4-methylthiosemicarbazone): effect of changes in tissue oxygenation. J Nucl Med. 2001; 42: 655–661.
  • 60
    Dehdashti F, Grigsby PW, Mintun MA, et al. Assessing tumor hypoxia in cervical cancer by positron emission tomography with (60)Cu-ATSM: relationship to therapeutic response—a preliminary report. Int J Radiat Oncol Biol Phys. 2003; 55: 1233–1238.
  • 61
    McCarthy DW, Shefer RE, Klinkowstein RE, et al. Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nucl Med Biol. 1997; 24: 35–43.
  • 62
    Dehdashti F, Mintun MA, Lewis JS, et al. In vivo assessment of tumor hypoxia in lung cancer with (60)Cu-ATSM. Eur J Nucl Med Mol Imaging. 2003; 30: 844–880.
  • 63
    Gould EA, Philbin WT, Hyland PH, Kerr H. Observations on a “sentinel node” in cancer of the parotid. Cancer. 1960; 13: 77–78.
    Direct Link:
  • 64
    Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 177; 39: 456–466.
  • 65
    Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992; 127: 392–399.
  • 66
    Levenback C, Burke TW, Bershenson DM, Morris M, Malpica A, Ross MI. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol. 1994; 84: 163–167.
  • 67
    Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 2001; 83: 276–281.
  • 68
    de Hullu JA, Hollema H, Piers DA, et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol. 2000; 18: 2811–2816.
  • 69
    De Cicco C, Sideri M, Bartolomei M, et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer. 2000; 82: 295–299.
  • 70
    Dargent D, Martin X, Mathevet P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol Oncol. 2000; 79: 411–415.
  • 71
    van Trappen PO, Gyselman VG, Lowe DG, et al. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet. 2001; 357: 15–20.
View Full Article (HTML) Get PDF (164K)